Skip to content

Lymphoma treatment outcomes just as good for people with HIV

Severe fibrosis improves in most people after hepatitis C cure but persists in a quarter

HPV16 highly prevalent among HIV-positive MSM in France and strongly associated with high-grade pre-cancerous anal lesions

PrEP does not raise lipids or alter body fat, safety study finds

Zambia: HIV deaths on treatment underestimated

Darunavir/ritonavir most durable boosted protease inhibitor in European patients, especially those switching treatment for any reason

High prevalence of hypertension among HIV-positive people in the US with 'missed opportunities' for its diagnosis and control

Communication skills training for healthcare workers improves HIV treatment adherence

US regulators approve new HIV combo pill containing bictegravir